Cargando…
Expression of FGFR1–4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity
Malignant pleural mesothelioma (MPM) is a devastating malignancy with limited therapeutic options. Fibroblast growth factor receptors (FGFR) and their ligands were shown to contribute to MPM aggressiveness and it was suggested that subgroups of MPM patients could benefit from FGFR-targeted inhibitor...
Autores principales: | Vlacic, Gregor, Hoda, Mir A., Klikovits, Thomas, Sinn, Katharina, Gschwandtner, Elisabeth, Mohorcic, Katja, Schelch, Karin, Pirker, Christine, Peter-Vörösmarty, Barbara, Brankovic, Jelena, Dome, Balazs, Laszlo, Viktoria, Cufer, Tanja, Rozman, Ales, Klepetko, Walter, Grasl-Kraupp, Bettina, Hegedus, Balazs, Berger, Walter, Kern, Izidor, Grusch, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769772/ https://www.ncbi.nlm.nih.gov/pubmed/31527449 http://dx.doi.org/10.3390/cells8091091 |
Ejemplares similares
-
Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis
por: Mosleh, Berta, et al.
Publicado: (2023) -
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study
por: Brcic, Luka, et al.
Publicado: (2021) -
FGF5 is expressed in melanoma and enhances malignancy in vitro and in vivo
por: Ghassemi, Sara, et al.
Publicado: (2017) -
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma
por: Hoda, Mir Alireza, et al.
Publicado: (2016) -
Interaction of FGF9 with FGFR3‐IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma
por: Paur, Jakob, et al.
Publicado: (2020)